Project Grant HT94252510379

Award Date 6/1/25
Completion Date 5/31/29
Dollars Obligated $4.2M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
The Leland Stanford Junior University was awarded a $4.72 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from March 2021 through March 2025 relating the interplay of tumor function and host response to clinical outcome in triple negative breast cancer. Through this award, Stanford University researchers will investigate medical solutions for breast cancer on the battlefield and...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...
The Leland Stanford Junior University received a $157,700 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research utilizing the immune response to tumor neoantigens for kidney cancer early detection. Through April 2022, Stanford University researchers will investigate medical solutions for the battlefield by exploring the potential of the body's immune response to detect and...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
The U.S. Department of Defense, through the Military Medical Research and Development (CFDA 12.420) program, awarded a $469,381 Project Grant to The Leland Stanford Junior University on Apr 15, 2025. The grant supports a 2-year research effort to engineer cytotoxic lymphocytes that can infiltrate ovarian cancer tumors using metabolite-sensing receptors. This work aims to transform healthcare for military service members and the broader public by advancing innovative cancer treatment...
The Leland Stanford Junior University (Stanford University) has been awarded a $370,866 federal Formula Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Uncovering Synthetically Lethal Genes in the Presence of Protein Folding Stress in Lung Cancer In Vivo," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research, to be...
The Leland Stanford Junior University (Stanford University) was awarded a $613,862 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will support research determining the predictive value, functional role, and mechanisms of action of NUSAP1 in clear cell renal cell carcinoma. Through this funding, Stanford University researchers will investigate medical solutions for kidney cancer with the goal of...

This federal Project Grant award of $4,232,760.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at The Leland Stanford Junior University (Stanford University) to help transform healthcare for military service members and the general public.

The goal of this 4-year award, which runs from June 1, 2025 to May 31, 2029, is to advance cure rates for infantile acute lymphoblastic leukemia through innovative and impactful research. Stanford University, a prestigious private research institution, will leverage its expertise in areas like cancer biology, medical technologies, and computational modeling to explore new approaches to disease prevention, diagnosis, treatment, and management of this critical condition affecting military personnel and veterans.

Generated 5/13/25, 4:48 AM